Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of somatic stem cell population maintenance. [GO_REF:0000058, GOC:BHF, GOC:BHF_miRNA, GOC:rph, GOC:TermGenie, PMID:19409607]
Somatic stem cells (SSCs) are undifferentiated cells that reside within specialized niches in tissues and organs, responsible for maintaining tissue homeostasis and regeneration. The regulation of SSC population maintenance is a complex process involving a delicate balance of factors that control self-renewal, differentiation, and apoptosis.
**1. Intrinsic Factors:**
* **Transcriptional Networks:** Key transcription factors like Oct4, Sox2, Nanog, and Klf4 play a crucial role in maintaining the undifferentiated state of SSCs. They regulate the expression of genes involved in cell cycle control, proliferation, and differentiation.
* **Epigenetic Modifications:** DNA methylation, histone modifications, and non-coding RNAs contribute to the establishment and maintenance of the SSC fate. These modifications regulate gene expression patterns crucial for stem cell identity and function.
* **Cell Cycle Regulation:** SSCs exhibit distinct cell cycle characteristics compared to differentiated cells. Tight control of cell cycle progression and the precise timing of cell division are essential for preserving the stem cell pool.
**2. Extrinsic Factors:**
* **Niche Microenvironment:** SSCs reside in specialized microenvironments called niches, which provide a supportive environment for stem cell maintenance. Niche components include:
* **Extracellular Matrix (ECM):** Provides structural support, adhesion cues, and signaling molecules.
* **Growth Factors and Cytokines:** Signaling molecules like Wnt, Shh, BMP, and TGF-β regulate SSC self-renewal, proliferation, and differentiation.
* **Other Cell Types:** Niche cells, such as mesenchymal stem cells, fibroblasts, and immune cells, interact with SSCs and contribute to niche function.
* **Metabolic Regulation:** SSCs exhibit unique metabolic profiles compared to differentiated cells. Metabolism is tightly regulated to ensure efficient energy production and maintain stem cell identity.
* **Oxygen Tension:** SSCs are often sensitive to oxygen levels, with hypoxic conditions favoring self-renewal and proliferation.
**3. Signaling Pathways:**
* **Wnt Signaling:** Plays a central role in regulating SSC self-renewal and preventing premature differentiation.
* **Hedgehog Signaling:** Regulates cell fate decisions and promotes SSC proliferation.
* **BMP Signaling:** Regulates differentiation and inhibits self-renewal.
* **Notch Signaling:** Controls cell fate decisions and promotes differentiation.
**4. Intercellular Communication:**
* **Cell-Cell Contact:** SSCs interact with niche cells through cell-cell adhesion molecules and gap junctions, facilitating signaling and regulation.
* **Paracrine Signaling:** Niche cells secrete factors that influence SSC behavior.
* **Juxtacrine Signaling:** Direct cell-to-cell communication mediated by membrane-bound proteins.
**5. Regulation of Apoptosis:**
* **Intrinsic and Extrinsic Apoptotic Pathways:** SSCs exhibit a balance between survival and apoptosis. Regulation of apoptotic pathways ensures that damaged or aged cells are eliminated while maintaining a healthy stem cell population.
**In summary, regulation of SSC population maintenance is a complex interplay of intrinsic and extrinsic factors that act together to maintain a delicate balance between self-renewal, differentiation, and apoptosis. Understanding these mechanisms is crucial for developing strategies for tissue regeneration, disease modeling, and therapeutic applications.**'
"
Protein | Definition | Taxonomy |
---|---|---|
Smoothened homolog | A protein smoothened that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q99835] | Homo sapiens (human) |
Myc proto-oncogene protein | A c-myc protein that is encoded in the genome of human. [PRO:CNA, UniProtKB:P01106] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
aurintricarboxylic acid | aurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'. Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues. | monohydroxybenzoic acid; quinomethanes; tricarboxylic acid | fluorochrome; histological dye; insulin-like growth factor receptor 1 antagonist |
mefenamic acid | mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis. Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase. | aminobenzoic acid; secondary amino compound | analgesic; antipyretic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-steroidal anti-inflammatory drug; xenobiotic |
methyl red | methyl red : An azo dye consisting of benzoic acid substituted at position 2 by a 4-[(dimethylamino)phenyl]diazenyl group. methyl red: RN given refers to parent cpd; structure | ||
3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine | 1,2,4-triazines | ||
avasimibe | monoterpenoid | ||
cyclopamine | piperidines | glioma-associated oncogene inhibitor | |
resveratrol | trans-resveratrol : A resveratrol in which the double bond has E configuration. | resveratrol | antioxidant; phytoalexin; plant metabolite; quorum sensing inhibitor; radical scavenger |
pd 173955 | PD 173955: inhibits src family-selective tyrosine kinase; structure in first source | aryl sulfide; dichlorobenzene; methyl sulfide; pyridopyrimidine | tyrosine kinase inhibitor |
10074-g5 | 10074-G5: structure in first source | ||
purmorphamine | purmorphamine : A member of the class of purines that is purine substituted at C-2 by a 1-naphthyloxy group, at C-4 by a 4-morpholinophenylamino group, and at N-9 by a cyclohexyl group. purmorphamine: structure in first source | aromatic ether; morpholines; purines; secondary amino compound | osteogenesis regulator; SMO receptor agonist |
cur 61414 | CUR 61414: inhibits the hedehog signaling pathway; structure in first source | ||
abt 869 | aromatic amine; indazoles; phenylureas | angiogenesis inhibitor; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor | |
lde225 | sonidegib : A member of the classo of biphenyls that is the amide obtained by formal condensation of the carboxy group of 2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxylic acid with the amino group of 6-(2,6-dimethylmorpholin-4-yl)pyridin-3-amine. Used (as its phosphate salt) for treatment of locally advanced basal cell carcinoma. sonidegib: specific Smoothened/Smo antagonist | aminopyridine; aromatic ether; benzamides; biphenyls; morpholines; organofluorine compound; tertiary amino compound | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist |
gdc 0449 | HhAntag691: inhibits the hedgehog pathway and ABC transporters; has antineoplastic activity | benzamides; monochlorobenzenes; pyridines; sulfone | antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist; teratogenic agent |
sgi-1027 | SGI-1027: inhibits DNA methyltransferase 1; structure in first source | ||
N-[[3-fluoro-4-[[2-(1-methyl-4-imidazolyl)-7-thieno[3,2-b]pyridinyl]oxy]anilino]-sulfanylidenemethyl]-2-phenylacetamide | thioureas | ||
ipi-926 | IPI-926: a semisynthetic derivative of cyclopamine that is a smoothened inhibitor with antineoplastic activity; structure in first source | piperidines | |
gsk 1363089 | GSK 1363089: a multikinase inhibitor that acts on Met, RON, Axl, and VEGFR; structure in first source | aromatic ether | |
tak-441 | TAK-441: structure in first source | ||
ly2940680 | |||
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | BGJ-398 : A member of the class of phenylureas that is urea in which a hydrogen attached to one of the nitrogens is replaced by a 2,6-dichloro-3,5-dimethoxyphenyl group, while the hydrogens attached to the other nitrogen are replaced by a methyl group and a 6-{[4-(4-ethylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl group. It is a potent and selective fibroblast growth factor receptor inhibitor. infigratinib: structure in first source | aminopyrimidine; dichlorobenzene; N-alkylpiperazine; N-arylpiperazine; phenylureas | antineoplastic agent; fibroblast growth factor receptor antagonist |
cep-32496 | agerafenib: inhibitor of RAF family kinases; structure in first source | ||
pf-5274857 | 1-(4-(5'-chloro-3,5-dimethyl-2,4'-bipyridin-2'-yl)piperazin-1-yl)-3-(methylsulfonyl)propan-1-one: a potent and selective Smoothened antagonist that penetrates the blood-brain barrier; structure in first source | ||
kj-pyr-9 | KJ-Pyr-9: antineoplastic; structure in first source |